Amniotic Fluid Steroid Levels: Fetuses With Adrenal Hyperplasia, 46,XXY Fetuses, and Normal Fetuses

Dennis J. Carson, Akimasa Okuno, Peter A. Lee, Claude J. Migeon

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Concentrations of testosterone, androstenedione, dehydroepiandrosterone (DHA), DHA sulfate (DHAS), progesterone, 17α-hydroxyprogesterone (17-OHP), and hydrocortisone were determined in amniotic fluid obtained at amniocentesis or at elective cesarean section. Male fetuses had significantly higher concentrations of testosterone and androstenedione than female fetuses had between 15 and 21 weeks of gestation but not near term (36 to 40 weeks). In both sexes, progesterone and 17-OHP concentrations fell and DHA, DHAS, and hydrocortisone concentrations increased significantly with advancing gestational age. Amniotic fluid 17-OHP, testosterone, DHA, and androstenedione levels from female fetuses with congenital adrenal hyperplasia (CAH) were more elevated in the second trimester than in the third. Three female fetuses at risk for CAH, but not affected, had normal steroid concentrations. Steroid concentrations from two fetuses with Klinefelter’s syndrome were not abnormal.

Original languageEnglish (US)
Pages (from-to)218-222
Number of pages5
JournalAmerican Journal of Diseases of Children
Volume136
Issue number3
DOIs
StatePublished - Mar 1982

Fingerprint

Amniotic Fluid
Hyperplasia
Fetus
Steroids
Dehydroepiandrosterone Sulfate
Androstenedione
Testosterone
Congenital Adrenal Hyperplasia
Dehydroepiandrosterone
Progesterone
Hydrocortisone
17-alpha-Hydroxyprogesterone
Klinefelter Syndrome
Amniocentesis
Second Pregnancy Trimester
Cesarean Section
Gestational Age
Pregnancy

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{1619da50b94e4e3b83a05fcd51daaac3,
title = "Amniotic Fluid Steroid Levels: Fetuses With Adrenal Hyperplasia, 46,XXY Fetuses, and Normal Fetuses",
abstract = "Concentrations of testosterone, androstenedione, dehydroepiandrosterone (DHA), DHA sulfate (DHAS), progesterone, 17α-hydroxyprogesterone (17-OHP), and hydrocortisone were determined in amniotic fluid obtained at amniocentesis or at elective cesarean section. Male fetuses had significantly higher concentrations of testosterone and androstenedione than female fetuses had between 15 and 21 weeks of gestation but not near term (36 to 40 weeks). In both sexes, progesterone and 17-OHP concentrations fell and DHA, DHAS, and hydrocortisone concentrations increased significantly with advancing gestational age. Amniotic fluid 17-OHP, testosterone, DHA, and androstenedione levels from female fetuses with congenital adrenal hyperplasia (CAH) were more elevated in the second trimester than in the third. Three female fetuses at risk for CAH, but not affected, had normal steroid concentrations. Steroid concentrations from two fetuses with Klinefelter’s syndrome were not abnormal.",
author = "Carson, {Dennis J.} and Akimasa Okuno and Lee, {Peter A.} and Migeon, {Claude J.}",
year = "1982",
month = "3",
doi = "10.1001/archpedi.1982.03970390032010",
language = "English (US)",
volume = "136",
pages = "218--222",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "3",

}

Amniotic Fluid Steroid Levels : Fetuses With Adrenal Hyperplasia, 46,XXY Fetuses, and Normal Fetuses. / Carson, Dennis J.; Okuno, Akimasa; Lee, Peter A.; Migeon, Claude J.

In: American Journal of Diseases of Children, Vol. 136, No. 3, 03.1982, p. 218-222.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Amniotic Fluid Steroid Levels

T2 - Fetuses With Adrenal Hyperplasia, 46,XXY Fetuses, and Normal Fetuses

AU - Carson, Dennis J.

AU - Okuno, Akimasa

AU - Lee, Peter A.

AU - Migeon, Claude J.

PY - 1982/3

Y1 - 1982/3

N2 - Concentrations of testosterone, androstenedione, dehydroepiandrosterone (DHA), DHA sulfate (DHAS), progesterone, 17α-hydroxyprogesterone (17-OHP), and hydrocortisone were determined in amniotic fluid obtained at amniocentesis or at elective cesarean section. Male fetuses had significantly higher concentrations of testosterone and androstenedione than female fetuses had between 15 and 21 weeks of gestation but not near term (36 to 40 weeks). In both sexes, progesterone and 17-OHP concentrations fell and DHA, DHAS, and hydrocortisone concentrations increased significantly with advancing gestational age. Amniotic fluid 17-OHP, testosterone, DHA, and androstenedione levels from female fetuses with congenital adrenal hyperplasia (CAH) were more elevated in the second trimester than in the third. Three female fetuses at risk for CAH, but not affected, had normal steroid concentrations. Steroid concentrations from two fetuses with Klinefelter’s syndrome were not abnormal.

AB - Concentrations of testosterone, androstenedione, dehydroepiandrosterone (DHA), DHA sulfate (DHAS), progesterone, 17α-hydroxyprogesterone (17-OHP), and hydrocortisone were determined in amniotic fluid obtained at amniocentesis or at elective cesarean section. Male fetuses had significantly higher concentrations of testosterone and androstenedione than female fetuses had between 15 and 21 weeks of gestation but not near term (36 to 40 weeks). In both sexes, progesterone and 17-OHP concentrations fell and DHA, DHAS, and hydrocortisone concentrations increased significantly with advancing gestational age. Amniotic fluid 17-OHP, testosterone, DHA, and androstenedione levels from female fetuses with congenital adrenal hyperplasia (CAH) were more elevated in the second trimester than in the third. Three female fetuses at risk for CAH, but not affected, had normal steroid concentrations. Steroid concentrations from two fetuses with Klinefelter’s syndrome were not abnormal.

UR - http://www.scopus.com/inward/record.url?scp=0020070058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020070058&partnerID=8YFLogxK

U2 - 10.1001/archpedi.1982.03970390032010

DO - 10.1001/archpedi.1982.03970390032010

M3 - Article

C2 - 7064946

AN - SCOPUS:0020070058

VL - 136

SP - 218

EP - 222

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 3

ER -